TVRD
Tvardi Therapeutics, Inc. Common Stock
TVRD
TVRD
33 hedge funds and large institutions have $3.21M invested in Tvardi Therapeutics, Inc. Common Stock in 2025 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 7 increasing their positions, 12 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
33
Holders Change
-9
Holders Change %
-21.43%
% of All Funds
0.45%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
7
Reduced
12
Closed
12
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
Bank of America
Charlotte,
North Carolina
|
+$135K |
2 |
UBS Group
Zurich,
Switzerland
|
+$55.9K |
3 |
AAP
Arax Advisory Partners
Denver,
Colorado
|
+$10.1K |
4 |
Geode Capital Management
Boston,
Massachusetts
|
+$8.54K |
5 |
![]()
JPMorgan Chase & Co
New York
|
+$471 |